Join us for a Seminar about Computational Pathology on September 14 - Dr. Rebecca Critchley-Thorne

Seminar: TissueCypherTM: A Systems Biology Approach to Anatomic Pathology

Dr. Rebecca Critchley-Thorne, Chief Scientific Officer at Cernostics, Inc, is giving a seminar on Monday, September 14, 2015 at 10:00am in room 6014 in BST3 (the conference room at the end of the bridge to BST3 on the sixth floor).  The seminar is part of the UPDDI seminar series.  Led by Chakra Chennubhotla, computational pathology has become an important component of our quantitative systems pharmacology (QSP) approach to personalized medicine and drug discovery/development.   We will have additional seminars on computational pathology, as well as other elements of our QSP approach during the coming year.  Cernostics is a local company that has pioneered the use of multiple cancer and stromal cell biomarkers from the tumor microenvironment in building predictive tests.  For full disclosure, Lans Taylor is a co-founder of the company.

 

View Rebecca Critchley-Thorne's Bio

View Cernostics Abstract:

Post Date: 
Thursday, August 20, 2015
^